Pharmacological Options in the Treatment of Benign Prostatic Hyperplasia

This publication has 60 references indexed in Scilit:

• Identification of α1-adrenoceptor subtypes present in the human prostate
  Published by Elsevier ,2002
• Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
  Clinical Pharmacokinetics, 1996
• Placebo Controlled Double-blind Study to Test the Efficacy of the Aromatase Inhibitor Atamestane in Patients with Benign Prostatic Hyperplasia not Requiring Operation
  Journal of Urology, 1995
• Cloning, functional expression and tissue distribution of human α_1C‐adrenoceptor splice variants
  FEBS Letters, 1995
• Pharmacological antagonism of ?-adrenergic agonist induced increases in canine intraurethral pressure in vivo
  Drug Development Research, 1995
• Effect of the optical isomers of YM‐12617 on increased intra‐urethral pressure induced by phenylephrine in anaesthetized dogs
  Journal of Autonomic Pharmacology, 1992
• 17β-acylurea derivatives of 4-azasteroids as inhibitors of testosterone 5α-reductase
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle
  The Prostate, 1992
• Characterisation of Human Prostatic Adrenoceptors using Pharmacology Receptor Binding and Localisation
  British Journal of Urology, 1989
• Indoramin-an Effective New Drug in the Management of Bladder Outflow Obstruction
  British Journal of Urology, 1987